Venkateswarlu K, Kelly S L
Krebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, University of Sheffield, UK.
FEMS Immunol Med Microbiol. 1996 Nov;16(1):11-20. doi: 10.1111/j.1574-695X.1996.tb00106.x.
The effect of ketoconazole on growth, sterol composition, in vitro sterol biosynthesis and P450-CO complex formation and its interaction with microsomal P450 was determined. On solid medium and in liquid medium ketoconazole inhibited Aspergillus fumigatus growth completely at 5 x 10(-5) M and 50% of the growth at 1.3 x 10(-5) M and 2.1 x 10(-5) M respectively. A close relationship between accumulation of 14 alpha-methyl sterols (eburicol, obtusifoliol and 14 alpha-methyl fecosterol) and depletion of ergosterol with growth arrest was observed in ketoconazole treated cultures. The half inhibitory concentration for in vitro ergosterol biosynthesis and half saturating concentration for type II binding spectrum of ketoconazole were calculated as 73.8 +/- 6.3 nM and 0.13 +/- 0.04 microM respectively. CO displacement studies revealed inhibition of CO-P450 complex formation by ketoconazole.
测定了酮康唑对生长、甾醇组成、体外甾醇生物合成以及P450-CO复合物形成的影响,及其与微粒体P450的相互作用。在固体培养基和液体培养基中,酮康唑在5×10⁻⁵M时完全抑制烟曲霉生长,在1.3×10⁻⁵M和2.1×10⁻⁵M时分别抑制50%的生长。在酮康唑处理的培养物中,观察到14α-甲基甾醇(羊毛甾醇、钝叶醇和14α-甲基麦角甾醇)的积累与麦角甾醇的消耗以及生长停滞之间存在密切关系。体外麦角甾醇生物合成的半抑制浓度和酮康唑II型结合谱的半饱和浓度分别计算为73.8±6.3 nM和0.13±0.04 μM。CO置换研究表明酮康唑抑制CO-P450复合物的形成。